Summary
56 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 16 USD is left as net profit.
- It holds more cash than debt: $16.3M against $4.26M.
- You pay 10.0 USD for 1 USD of yearly profit, little for its sector.
- Revenue grew by 10% a year over the last 3 years.
What to watch
- It reports a profit, yet spends more cash than it brings in.
- It passes only 2 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 6 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapToday you pay 10.0 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 53% a year over 5 years. Over the last 3 years it grew by 10% a year.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 79 USD
- Research and development 0.2 USD
- Sales and administration 28 USD
- Taxes and other -24 USD
- Net profit 16 USD
Net profit, industry median (Medical - Care Facilities) 6.7 USD
Out of every 100 USD of revenue, 16 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 6
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $7.25 is 56% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Logistics 90%
- Clinical 10%
By region
- UNITED STATES 88%
- Non-US 12%
Logistics brings in 90% of revenue.
Segments in detail